Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

(NIH/National Center for Advancing Translational Sciences (NCATS)) The NIH has launched a phase 3 clinical trial to examine the use of prescription and over-the-counter medications for people with mild-to-moderate COVID-19. These individuals are not sick enough to be hospitalized. The trial is part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership. NIH will provide an initial investment of $155 million in funding for the trial, which will be o...